📇 Rhumatologue · FORT DE FRANCE CEDEX · (972) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Centre hospitalier universitaire (CHU) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
38 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
106.4 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CHU DE MARTINIQUE SITE P.ZOBDA QUITMAN
QUA LA MEYNARD CS 90632, 97261 FORT DE FRANCE CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Annals of neurology · 2015
ObjectiveTo compare the natural history of familial transthyretin amyloid polyneuropathies (FAP) due to the Val30Met, Ser77Tyr, and Ile107Val mutations in France with the classical Portuguese Val30Met FAP.MethodsWe compared 84 French patients with a control group of 110 Portuguese patients carrying the Val30Met mutation also living in France, all referred to and followed at the French National FAP Reference Center from 1988 to 2010. Clinical examination, functional and walking disability scores, nerve conduction studies, and muscle biopsies are reported. We also conducted a comprehensive literature review to further determine the range of phenotypic expression.ResultsBy comparison with Portuguese Val30Met FAP, French Ile107Val, Ser77Tyr, and LateVal30Met FAP showed more rapid and severe disease progression; onset of gait disorders was 3 times more rapid (p < 0.0001) and the rate of modified Norris test decline was up to 40 times faster in Ile107Val patients (p < 0.0001). Median survival was much shorter in Ile107Val and in Val30Met mutation with late onset (>50 years; LateMet30) FAP (p = 0.0005). Other distinctive features relative to the Portuguese patients included atypical clinical presentations, demyelination on nerve conduction studies (p = 0.0005), and difficult identification of amyloid deposits in nerve and muscle biopsies.InterpretationIle107Val and LateMet30 mutations are associated with the most debilitating and severe FAP ever described, with rapid onset of tetraparesis and shorter median survival. It could be explained by frequent large‐fiber involvement and associated demyelination and more severe axonal loss. These findings have major implications for genetic counseling and patient management as new therapeutic options are being assessed in clinical trials (TTR gene silencing). Ann Neurol 2015;78:901–916
Journal of the neurological sciences · 2005
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2016
We report two cases of Guillain–Barré syndrome who had concomitant Zika virus viruria. This viruria persisted for longer than 15 days after symptom onset. The cases occurred on Martinique in January 2016, at the beginning of the Zika virus outbreak. Awareness of this possible neurological complication of ZikV infection is needed.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Movement disorders clinical practice · 2026 · Journal Article
Antolin-Sanfeliz I, Giguet-Valard AG, Duclos S, Cazeneuve C, et al.
Stroke · 2025 · Journal Article
Poirette P, Chausson N, Papaxanthos J, Kyheng M, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Bourgeois-Beauvais Q, Sellin D, Arnaud I, Tuttle C, et al.
Orphanet journal of rare diseases · 2025 · Journal Article
Péréon Y, Adams D, Camdessanché JP, Chanson JB, et al.
European journal of neurology · 2025 · Comparative Study
David T, Lobjois Q, Tressières B, Signaté A, et al.
Neurology(R) neuroimmunology & neuroinflammation · 2024 · Observational Study
Chaumont H, Bérard N, Karam JP, Lobjois Q, et al.
Medecine sciences : M/S · 2023 · Journal Article
Bellance R, Antolín Sanféliz I, Duclos S, Guiget-Valard AG, et al.
Biomedicines · 2022 · Journal Article
Louis-Sidney F, Duby JF, Signate A, Arfi S, et al.
Frontiers in neurology · 2022 · Journal Article
Banydeen R, Signate A, Tran TH, Monfort A, et al.
Multiple sclerosis journal - experimental, translational and clinical · 2021 · Journal Article
Bonnan M, Olindo S, Signate A, Lobjois Q, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020 · Journal Article
Stegmann-Planchard S, Gallian P, Tressières B, Leparc-Goffart I, et al.
Neurology · 2019 · Journal Article
Lannuzel A, Fergé JL, Lobjois Q, Signate A, et al.
American journal of epidemiology · 2017 · Journal Article
Andronico A, Dorléans F, Fergé JL, Salje H, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017 · Journal Article
Rozé B, Najioullah F, Fergé JL, Dorléans F, et al.
International journal of stroke : official journal of the International Stroke Society · 2017 · Journal Article
Olindo S, Saint-Vil M, Jeannin S, Signate A, et al.
The American journal of tropical medicine and hygiene · 2017 · Journal Article
Balavoine S, Pircher M, Hoen B, Herrmann-Storck C, et al.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2016 · Case Reports
Rozé B, Najioullah F, Signate A, Apetse K, et al.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2016 · Case Reports
Rozé B, Najioullah F, Fergé JL, Apetse K, et al.
Annals of neurology · 2015 · Journal Article
Mariani LL, Lozeron P, Théaudin M, Mincheva Z, et al.
Clinical neurology and neurosurgery · 2013 · Journal Article
Joux J, Olindo S, Girard-Claudon A, Chausson N, et al.
Archives of neurology · 2012 · Journal Article
Olindo S, Chausson N, Joux J, Saint - Vil M, et al.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2012 · Journal Article
Adams D, Lozeron P, Theaudin M, Mincheva Z, et al.
Stroke · 2011 · Journal Article
Smadja D, Chausson N, Joux J, Saint-Vil M, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2010 · Case Reports
Chausson N, Bocquet J, Aveillan M, Olindo S, et al.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2010 · Journal Article
Deschamps R, Béra O, Belrose G, Lezin A, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2010 · Case Reports
Olindo S, Bonnan M, Merle H, Signate A, et al.
Revue neurologique · 2010 · Case Reports
Chausson N, Olindo S, Signaté A, Cohen-Ténoudji P, et al.
Frontiers in bioscience (Scholar edition) · 2009 · Journal Article
Lezin A, Olindo S, Belrose G, Signate A, et al.
Blood · 2007 · Journal Article
Lezin A, Gillet N, Olindo S, Signaté A, et al.
Archives of neurology · 2006 · Comparative Study
Olindo S, Cabre P, Lézin A, Merle H, et al.
Journal of the neurological sciences · 2005 · Journal Article
Olindo S, Lézin A, Cabre P, Merle H, et al.
International journal of stroke : official journal of the International Stroke Society · 2024 · Journal Article
Olindo S, Gaillard N, Chausson N, Turpinat C, et al.
Journal of stroke · 2021 · Journal Article
Olindo S, Chausson N, Signate A, Mecharles S, et al.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2024 · Journal Article
Fargeot G, Echaniz-Laguna A, Labeyrie C, Svahn J, et al.
Magnetic resonance imaging · 2023 · Journal Article
Pavilla A, Gambarota G, Signaté A, Arrigo A, et al.
Blood · 2011 · Controlled Clinical Trial
Olindo S, Belrose G, Gillet N, Rodriguez S, et al.
Clinical, imaging, and management features of symptomatic carotid web: Insight from CAROWEB registry
Background:Although carotid web (CaW) is increasingly diagnosed as a cause of cryptogenic stroke, data are still limited to monocentric small sample cohort. To broaden knowledge on symptomatic CaW, CAROWEB registry has b
NMOSD-like and longitudinal extensive HTLV1-associated myelitis are extremes that flank an overlooked continuum
BackgroundHTLV1-associated myelitis (HAM) is a slowly progressive myelopathy in which spinal cord MRI demonstrates no lesion or atrophy.ObjectiveWe examined the overlap between NMOSD features and HTLV1 infection.MethodsW
NMOSD-like and longitudinal extensive HTLV1-associated myelitis are extremes that flank an overlooked continuum
BackgroundHTLV1-associated myelitis (HAM) is a slowly progressive myelopathy in which spinal cord MRI demonstrates no lesion or atrophy.ObjectiveWe examined the overlap between NMOSD features and HTLV1 infection.MethodsW
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study
Hereditary transthyretin amyloidosis (ATTRv) is an adult-onset autosomal dominant disease resulting from <i>TTR</i> gene pathogenic variants. ATTRv often presents as a progressive polyneuropathy, and effective ATTRv trea
NeuroZika study, Lannuzel et al.
Supplementary figure S1 and supplementary Tables S1-5
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study
Hereditary transthyretin amyloidosis (ATTRv) is an adult-onset autosomal dominant disease resulting from <i>TTR</i> gene pathogenic variants. ATTRv often presents as a progressive polyneuropathy, and effective ATTRv trea
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
PLoS neglected tropical diseases · 2018 · Journal Article
Olindo S, Jeannin S, Saint-Vil M, Signate A, et al.
Stroke · 2014 · Journal Article
Olindo S, Chausson N, Mejdoubi M, Jeannin S, et al.